ALC
Price
$89.30
Change
+$0.28 (+0.31%)
Updated
Jul 2 closing price
Capitalization
40.86B
48 days until earnings call
SYK
Price
$391.75
Change
-$4.99 (-1.26%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
134.94B
29 days until earnings call
Interact to see
Advertisement

ALC vs SYK

Header iconALC vs SYK Comparison
Open Charts ALC vs SYKBanner chart's image
Alcon
Price$89.30
Change+$0.28 (+0.31%)
Volume$1.22M
Capitalization40.86B
Stryker
Price$391.75
Change-$4.99 (-1.26%)
Volume$7.37K
Capitalization134.94B
ALC vs SYK Comparison Chart in %
Loading...
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALC vs. SYK commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Buy and SYK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ALC: $89.30 vs. SYK: $391.81)
Brand notoriety: ALC and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALC: 77% vs. SYK: 89%
Market capitalization -- ALC: $40.86B vs. SYK: $134.94B
ALC [@Medical Specialties] is valued at $40.86B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than ALC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).

  • ALC’s TA Score: 4 bullish, 5 bearish.
  • SYK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SYK is a better buy in the short-term than ALC.

Price Growth

ALC (@Medical Specialties) experienced а +1.98% price change this week, while SYK (@Medical Specialties) price change was +0.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.11%. For the same industry, the average monthly price growth was +2.71%, and the average quarterly price growth was -0.52%.

Reported Earning Dates

ALC is expected to report earnings on Aug 20, 2025.

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+2.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than ALC($40.9B). SYK (42.99) and ALC (41.85) have similar P/E ratio . SYK YTD gains are higher at: 10.681 vs. ALC (5.195). SYK has higher annual earnings (EBITDA): 4.93B vs. ALC (2.24B). SYK has more cash in the bank: 3.05B vs. ALC (1.1B). ALC has less debt than SYK: ALC (5.14B) vs SYK (13B). SYK has higher revenues than ALC: SYK (20.5B) vs ALC (9.46B).
ALCSYKALC / SYK
Capitalization40.9B135B30%
EBITDA2.24B4.93B45%
Gain YTD5.19510.68149%
P/E Ratio41.8542.9997%
Revenue9.46B20.5B46%
Total Cash1.1B3.05B36%
Total Debt5.14B13B40%
FUNDAMENTALS RATINGS
ALC vs SYK: Fundamental Ratings
ALC
SYK
OUTLOOK RATING
1..100
1418
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
4913
SMR RATING
1..100
8256
PRICE GROWTH RATING
1..100
5634
P/E GROWTH RATING
1..100
6419
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (22) in the Medical Specialties industry is somewhat better than the same rating for ALC (70) in the Hospital Or Nursing Management industry. This means that SYK’s stock grew somewhat faster than ALC’s over the last 12 months.

SYK's Profit vs Risk Rating (13) in the Medical Specialties industry is somewhat better than the same rating for ALC (49) in the Hospital Or Nursing Management industry. This means that SYK’s stock grew somewhat faster than ALC’s over the last 12 months.

SYK's SMR Rating (56) in the Medical Specialties industry is in the same range as ALC (82) in the Hospital Or Nursing Management industry. This means that SYK’s stock grew similarly to ALC’s over the last 12 months.

SYK's Price Growth Rating (34) in the Medical Specialties industry is in the same range as ALC (56) in the Hospital Or Nursing Management industry. This means that SYK’s stock grew similarly to ALC’s over the last 12 months.

SYK's P/E Growth Rating (19) in the Medical Specialties industry is somewhat better than the same rating for ALC (64) in the Hospital Or Nursing Management industry. This means that SYK’s stock grew somewhat faster than ALC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCSYK
RSI
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 15 days ago
57%
Bearish Trend 15 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HPS14.460.17
+1.19%
John Hancock Preferred Income Fund III
MSLC51.230.19
+0.37%
Morgan Stanley Pathway Large Cap Eq ETF
KF26.990.09
+0.33%
Korea Fund
RSPE27.920.05
+0.16%
Invesco ESG S&P 500 Equal Weight ETF
UTG35.82-0.40
-1.10%
Reaves Utility Income Fund